Skip to content
Recall Observatory FDA recall evidence

Drug product

Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA

D-0306-2020

November 01, 2019

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 84196
Status
Terminated
Classification
Class III
Quantity
a) 4074 bottles b) 30,300 bottles
Official record key
drug-enforcement:D-0306-2020

Official wording

Reason: Presence of Foreign substance: identified as a dead ant.

Code information: Lot #: a) F900153, Exp 11/20; b) F802327, F802328, F802329, Exp 11/20

Distribution pattern: Product was distributed to major distributors/wholesalers throughout the United States.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign substance